| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |